A NOVEL OFFICE-BASED INJECTABLE TO TREAT DUCHENNE-RELATED FIBROSIS

$1,011,531FY2021Defense Health AgencyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators

View source on USAspending →

A NOVEL OFFICE-BASED INJECTABLE TO TREAT DUCHENNE-RELATED FIBROSIS · GrantIndex